# S-Caine™ Peel (Skin Numbing Cream) to Treat Pain During Pulsed Dye Laser (PDL) Therapy in Adults

> **NCT00110773** · PHASE3 · COMPLETED · sponsor: **ZARS Pharma Inc.** · enrollment: 80 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** S-Caine™ Peel (lidocaine and tetracaine topical cream 7%/7%)
- **DRUG:** Placebo Peel

## Key facts

- **NCT ID:** NCT00110773
- **Lead sponsor:** ZARS Pharma Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-06
- **Primary completion:** 2005-10
- **Final completion:** 2005-10
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2012-06-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00110773

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00110773, "S-Caine™ Peel (Skin Numbing Cream) to Treat Pain During Pulsed Dye Laser (PDL) Therapy in Adults". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT00110773. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*